Literature DB >> 18407600

DNMT3B 579 G>T promoter polymorphism and risk of esophagus carcinoma in Chinese.

Hong Fan1, Dong-Sheng Liu, Shu-Hong Zhang, Jia-Bo Hu, Feng Zhang, Zhu-Jiang Zhao.   

Abstract

AIM: To investigate the relationship between 579 G>T polymorphisms in the DNMT3B gene, which is involved in de novo methylation and associated with the risk of esophagus cancer (EC) in Chinese.
METHODS: DNMT3B 579 G>T genotypes were determined by PCR-RFLP in 194 EC patients and 210 healthy controls matched for age and sex, who did not receive radiotherapy or chemotherapy for newly diagnosed and histopathologically confirmed EC.
RESULTS: In control subjects, the frequency of T/T and G/T genotypes, and T and G alleles was 81.4%, 18.1%, 90.05% and 9.55%, respectively. The distribution of genotypes and allelotypes in the EC patients was not significantly different from that in the controls. When stratified by sex and age, there was still no significant association between the risks of EC and GT and GG genotypes. This study also showed a distinct difference in the distribution of DNMT3B and single nucleotide polymorphism (SNP) between Chinese and Koreans.
CONCLUSION: DNMT3B 579 G>T polymorphism may not be a stratification marker to predict the susceptibility to EC, at least in Chinese. DNMT3B promoter SNP is diverse in ethnic populations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18407600      PMCID: PMC2703851          DOI: 10.3748/wjg.14.2230

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

1.  Distinct DNA methylation activity of Dnmt3a and Dnmt3b towards naked and nucleosomal DNA.

Authors:  Hideyuki Takeshima; Isao Suetake; Hideto Shimahara; Kiyoe Ura; Shin-ichi Tate; Shoji Tajima
Journal:  J Biochem       Date:  2006-03       Impact factor: 3.387

2.  Single nucleotide polymorphism in DNA methyltransferase 3B promoter and its association with gastric cardiac adenocarcinoma in North China.

Authors:  Yi-Min Wang; Rui Wang; Deng-Gui Wen; Yan Li; Wei Guo; Na Wang; Li-Zhen Wei; Yu-Tong He; Zhi-Feng Chen; Xiu-Feng Zhang; Jian-Hui Zhang
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

3.  Lower expression of p14ARF and p16INK4a correlates with higher DNMT3B expression in human oesophageal squamous cell carcinomas.

Authors:  Tatiana de Almeida Simão; Gabriela Loureiro De Bonis Almeida Simões; Fabiana Siqueira Ribeiro; Daniela Anhel de Paula Cidade; Nelson Adami Andreollo; Luiz Roberto Lopes; Jacyara Maria Brito Macedo; Rodolfo Acatauassu; Ana Maria Rossini Teixeira; Israel Felzenszwalb; Luis Felipe Ribeiro Pinto; Rodolpho Mattos Albano
Journal:  Hum Exp Toxicol       Date:  2006-09       Impact factor: 2.903

4.  Molecular enzymology of the catalytic domains of the Dnmt3a and Dnmt3b DNA methyltransferases.

Authors:  Humaira Gowher; Albert Jeltsch
Journal:  J Biol Chem       Date:  2002-03-27       Impact factor: 5.157

5.  Genetic variants in epigenetic genes and breast cancer risk.

Authors:  Arancha Cebrian; Paul D Pharoah; Shahana Ahmed; Santiago Ropero; Mario F Fraga; Paula L Smith; Don Conroy; Robert Luben; Barbara Perkins; Douglas F Easton; Alison M Dunning; Manel Esteller; Bruce A J Ponder
Journal:  Carcinogenesis       Date:  2006-02-25       Impact factor: 4.944

6.  A common functional polymorphism (C-->A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha.

Authors:  T Skoog; F M van't Hooft; B Kallin; S Jovinge; S Boquist; J Nilsson; P Eriksson; A Hamsten
Journal:  Hum Mol Genet       Date:  1999-08       Impact factor: 6.150

7.  Expression of Delta DNMT3B variants and its association with promoter methylation of p16 and RASSF1A in primary non-small cell lung cancer.

Authors:  Jie Wang; Garret Walsh; Diane D Liu; J Jack Lee; Li Mao
Journal:  Cancer Res       Date:  2006-09-01       Impact factor: 12.701

8.  An essential role for DNA methyltransferase DNMT3B in cancer cell survival.

Authors:  Normand Beaulieu; Steves Morin; Ian C Chute; Marie-France Robert; Hannah Nguyen; A Robert MacLeod
Journal:  J Biol Chem       Date:  2002-05-15       Impact factor: 5.157

9.  Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis.

Authors:  Yoshimasa Saito; Yae Kanai; Michiie Sakamoto; Hidetsugu Saito; Hiromasa Ishii; Setsuo Hirohashi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-10       Impact factor: 11.205

10.  Hypermethylation of the inducible nitric-oxide synthase gene promoter inhibits its transcription.

Authors:  Zhiyuan Yu; Bruce C Kone
Journal:  J Biol Chem       Date:  2004-08-11       Impact factor: 5.157

View more
  18 in total

1.  Genetic variation in the promoter of DNMT3B is associated with the risk of colorectal cancer.

Authors:  Qian Bao; Bangshun He; Yuqin Pan; Zhipeng Tang; Ying Zhang; Lili Qu; Yongfei Xu; Chan Zhu; Fuliang Tian; Shukui Wang
Journal:  Int J Colorectal Dis       Date:  2011-04-26       Impact factor: 2.571

2.  DNMT3B polymorphisms and cancer risk: a meta analysis of 24 case-control studies.

Authors:  Shimiao Zhu; Hui Zhang; Yang Tang; Peicai Liu; Jianmin Wang
Journal:  Mol Biol Rep       Date:  2011-09-22       Impact factor: 2.316

3.  The DNMT3B -579 G>T promoter polymorphism and risk of lung cancer.

Authors:  Hui Liu; Yifei Jiao; Yana Guan; Yingbin Lao; Chengcheng Zhao; Hong Fan
Journal:  Exp Ther Med       Date:  2011-12-19       Impact factor: 2.447

4.  DNMT3B -579 G>T promoter polymorphism and risk of gallbladder carcinoma in North Indian population.

Authors:  Kshitij Srivastava; Anvesha Srivastava; Balraj Mittal
Journal:  J Gastrointest Cancer       Date:  2010-12

5.  DNMT3B -579 G>T Promoter Polymorphism and the Risk of Gastric Cancer in the West of Iran.

Authors:  Kulsom Ahmadi; Azam Soleimani; Shiva Irani; Aliasghar Kiani; Kourosh Ghanadi; Zahra Noormohamadi; Foroozan Sakinejad
Journal:  J Gastrointest Cancer       Date:  2018-06

Review 6.  Systematic evaluation of cancer risk associated with DNMT3B polymorphisms.

Authors:  Fujiao Duan; Shuli Cui; Chunhua Song; Liping Dai; Xia Zhao; Xiaoqin Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2014-12-11       Impact factor: 4.553

7.  DNMT3B promoter polymorphism and risk of gastric cancer.

Authors:  Jiabo Hu; Hong Fan; Dongsheng Liu; Shuhong Zhang; Feng Zhang; Huaxi Xu
Journal:  Dig Dis Sci       Date:  2009-06-11       Impact factor: 3.199

8.  A functional polymorphism in the DNA methyltransferase-3A promoter modifies the susceptibility in gastric cancer but not in esophageal carcinoma.

Authors:  Hong Fan; Dongsheng Liu; Xuemei Qiu; Fengchang Qiao; Qingxiang Wu; Xianwei Su; Feng Zhang; Yunwei Song; Zhujiang Zhao; Wei Xie
Journal:  BMC Med       Date:  2010-02-03       Impact factor: 8.775

9.  Association of the DNMT3B polymorphism with colorectal adenomatous polyps and adenocarcinoma.

Authors:  Xiaoqing Guo; Liwei Zhang; Mingli Wu; Na Wang; Yanfeng Liu; Limian Er; Shunping Wang; Yang Gao; Weifang Yu; Hui Xue; Zhibin Xu; Shijie Wang
Journal:  Mol Biol Rep       Date:  2009-07-22       Impact factor: 2.316

10.  Association of the DNMT3A -448A>G polymorphism with genetic susceptibility to colorectal cancer.

Authors:  Zhujiang Zhao; Can Li; Yunwei Song; Qunying Wu; Fengchang Qiao; Hong Fan
Journal:  Oncol Lett       Date:  2011-11-17       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.